- €647.20m
- €3.58bn
- €305.45m
- 14
- 60
- 50
- 33
2019 December 31st | 2020 December 31st | 2021 December 31st | R2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Interest Income | |||||
Interest Expense | |||||
Net Interest Income | 77.6 | 80.7 | 96.3 | 99.2 | 144 |
Loan Loss Provision | |||||
Net Interest Income After Loan Loss Provision | 73.1 | 76.6 | 91.8 | 89 | 137 |
Non Interest Income | |||||
Non Interest Expense | |||||
Net Income Before Taxes | 74.8 | 54.8 | 84.6 | 124 | 106 |
Provision for Income Taxes | |||||
Net Income After Taxes | 61.8 | 42.6 | 67.4 | 98.3 | 84.2 |
Net Income Before Extraordinary Items | |||||
Net Income | 61.8 | 42.6 | 67.4 | 98.3 | 84.2 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 61.8 | 42.6 | 66.8 | 98.3 | 84.2 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.937 | 0.612 | 0.98 | 1.38 | 1.2 |
Dividends per Share |